Elbow Lesion Treatment: Introduction
- Elbow lesion are injuries that disrupt the cartilage and subjacent bone, and most commonly involve the capitellum. Factors that can result in elbow lesion include genetics, improper nutrition, and trauma.
- The staging, prognosis, and treatment of lesions in the elbow are based on a combination of radiographic, magnetic resonance imaging, and arthroscopic findings
- Elbow lesion is most often witnessed in adolescents aged between 12 years and 16 years who are throwing athletes, overhead athletes, or upper extremity weight bearing athletes
- Baseball and gymnastics are common sports of patients with capitellar osteochondritis lesions. It is perceived to be due to repetitive microtrauma to the capitellum with valgus elbow loading.
- Osteochondritis dissecans of the elbow is prevalent in pediatric population in the U.S., especially in young athletes such as basketball players
Key Drivers of Global Elbow Lesion Treatment Market
- Health care awareness and rise in adventure sports have led to an increase in the incidence rate of sports injuries. According to the Johns Hopkins Medicine Organization, about 30 million teen and children participate in the some form of sport in the U.S., and over 3.5 children ages 14 and younger get hurt annually participating in recreational activities or playing sports.
- Over 775,000 children, ages 14 and younger, are treated in hospital emergency rooms for sports-related injuries each year
- Increase in the incidence rate of sports injuries among youth is due to excess pressure on joints and repeated small trauma injuries. Therefore, increased participation in sports and exercise has led to a rise in sports-related injuries, and consequently higher demand for elbow lesions management products such as elbow splints.
- Large number of global manufacturers who have technical expertise and core competencies are undertaking constant efforts to develop and manufacture novel elbow lesion treatment products. Improved biomaterial-based products with high strength and low wear are witnessing an exponential rise in the demand in developed as well as developing countries. Moreover, there is a rise in the adoption of minimally invasive surgery (MIS), navigation technology, 3D-bioprinting, and tissue engineering. Affordability, ease of utility, and novelty are key factors for product developers to cater to the increasing demand of the rapidly growing population affected by orthopedic diseases.
Surgical Treatment to be Highly Attractive Segment of Global Elbow Lesion Treatment Market
- In terms of type, the global elbow lesion treatment market can be classified into surgical and non-surgical treatment
- The surgical treatment segment can be further sub-segmented into anthroscopic surgery and open surgery. The non-surgical treatment segment can be further split into drug therapy such as NSAIDs, platelet-rich plasma, and physical therapy.
- Incidence of accidental injuries during sports, driving, and adventure has increased drastically in the last decade. According to Centers for Disease Control and Prevention (CDC), every year, over 2 million patients visit the U.S. emergency departments for head trauma related injuries.
North America to Dominate Global Elbow Lesion Treatment Market
- In terms of region, the global elbow lesion treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to lead the global elbow lesions treatment market. The elbow lesion treatment market in North America is driven by a well-established healthcare infrastructure in the region. This has led to a rise in the number of surgeries, which in turn contributes to the prominent share of the region in the global market.
- This market in Europe is projected to expand due to rising patient pool of geriatric population, high incidences of lifestyle disorders, and technological advancements in the region
- The elbow lesion treatment market in Asia Pacific is anticipated to expand at a rapid pace, owing to a rise in medical tourism, increasing efforts by governments of developing countries to better the health care infrastructure, and technological advancements in the region
Key Players Operating in Global Elbow Lesion Treatment Market
Key players operating in the global elbow lesion treatment market are:
- Arthrex, Inc.
- Stryker
- Zimmer Biomet
- DePuy Synthes (Johnson & Johnson)
- Exactech, Inc.
- Cesca Therapeutics Inc,
- Cesca Therapeutics
- Hanger, Inc.
- Fillauer LLC
Global Elbow Lesion Treatment Market: Research Scope
Global Elbow Lesion Treatment Market, by Type
- Surgical Treatment
- Anthroscopic Surgery
- Open Surgery
- Non-surgical Treatment
- Drug Therapy
- Platelet-rich Plasma
- Physical Therapy
Global Elbow Lesion Treatment Market, by End-user
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
Global Elbow Lesion Treatment Market, by Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Interested in this report?
Get a FREE Brochure now!
